ArcherDX’s Companion Diagnostic Assay for both Liquid Biopsy and Tissue Specimens Granted Breakthrough Device Designation by FDA January 8, 2019
Calithera Biosciences Provides Corporate Updates and Announces Key Executive Promotions to Drive Continued Growth of the Company’s Pipeline January 7, 2019
Verastem Oncology Outlines Strategic Priorities for 2019 and Highlights Recent Progress January 3, 2019
